Matches in Wikidata for { <http://www.wikidata.org/entity/Q81284330> ?p ?o ?g. }
- Q81284330 description "2005 nî lūn-bûn" @default.
- Q81284330 description "2005年の論文" @default.
- Q81284330 description "2005年学术文章" @default.
- Q81284330 description "2005年学术文章" @default.
- Q81284330 description "2005年学术文章" @default.
- Q81284330 description "2005年学术文章" @default.
- Q81284330 description "2005年学术文章" @default.
- Q81284330 description "2005年学术文章" @default.
- Q81284330 description "2005年學術文章" @default.
- Q81284330 description "2005年學術文章" @default.
- Q81284330 description "2005年學術文章" @default.
- Q81284330 description "2005年學術文章" @default.
- Q81284330 description "2005年學術文章" @default.
- Q81284330 description "2005년 논문" @default.
- Q81284330 description "article científic" @default.
- Q81284330 description "article scientific" @default.
- Q81284330 description "article scientifique" @default.
- Q81284330 description "articol științific" @default.
- Q81284330 description "articolo scientifico" @default.
- Q81284330 description "artigo científico" @default.
- Q81284330 description "artigo científico" @default.
- Q81284330 description "artigo científico" @default.
- Q81284330 description "artikel ilmiah" @default.
- Q81284330 description "artikull shkencor" @default.
- Q81284330 description "artikulong pang-agham" @default.
- Q81284330 description "artykuł naukowy" @default.
- Q81284330 description "artículo científico publicado en 2005" @default.
- Q81284330 description "artículu científicu" @default.
- Q81284330 description "bilimsel makale" @default.
- Q81284330 description "bài báo khoa học" @default.
- Q81284330 description "naučni članak" @default.
- Q81284330 description "scienca artikolo" @default.
- Q81284330 description "scientific article published in January 2005" @default.
- Q81284330 description "scientific article published in January 2005" @default.
- Q81284330 description "scientific article published on 01 January 2005" @default.
- Q81284330 description "teaduslik artikkel" @default.
- Q81284330 description "tieteellinen artikkeli" @default.
- Q81284330 description "tudományos cikk" @default.
- Q81284330 description "vedecký článok" @default.
- Q81284330 description "vetenskaplig artikel" @default.
- Q81284330 description "videnskabelig artikel udgivet januar 2005" @default.
- Q81284330 description "vitenskapelig artikkel" @default.
- Q81284330 description "vitskapeleg artikkel" @default.
- Q81284330 description "vědecký článek" @default.
- Q81284330 description "wetenschappelijk artikel" @default.
- Q81284330 description "wissenschaftlicher Artikel" @default.
- Q81284330 description "επιστημονικό άρθρο" @default.
- Q81284330 description "мақолаи илмӣ" @default.
- Q81284330 description "наукова стаття, опублікована в січні 2005" @default.
- Q81284330 description "научна статия" @default.
- Q81284330 description "научная статья" @default.
- Q81284330 description "научни чланак" @default.
- Q81284330 description "научни чланак" @default.
- Q81284330 description "מאמר מדעי" @default.
- Q81284330 description "مقالة علمية نشرت في يناير 2005" @default.
- Q81284330 description "জানুয়ারি ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q81284330 description "บทความทางวิทยาศาสตร์" @default.
- Q81284330 description "სამეცნიერო სტატია" @default.
- Q81284330 name "Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis" @default.
- Q81284330 name "Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis" @default.
- Q81284330 name "Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis" @default.
- Q81284330 type Item @default.
- Q81284330 label "Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis" @default.
- Q81284330 label "Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis" @default.
- Q81284330 label "Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis" @default.
- Q81284330 prefLabel "Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis" @default.
- Q81284330 prefLabel "Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis" @default.
- Q81284330 prefLabel "Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis" @default.
- Q81284330 P1433 Q81284330-50648215-C24D-490A-A971-9652FBBF9499 @default.
- Q81284330 P1476 Q81284330-23F9D08A-D6C9-4A59-9314-FA8A61784A3A @default.
- Q81284330 P2093 Q81284330-20C9E3E9-0580-40CC-B24D-30EEFA82E987 @default.
- Q81284330 P2093 Q81284330-4AEC0A9F-E350-4C19-8C91-529787F6DB6E @default.
- Q81284330 P2093 Q81284330-4F743BD5-7968-47D3-BCA1-DE4281BDC253 @default.
- Q81284330 P2093 Q81284330-78E1E0E5-204D-4747-9440-3763B5661D00 @default.
- Q81284330 P2093 Q81284330-B6FA9E24-D62C-4AF1-98B4-415AB6A3759E @default.
- Q81284330 P2093 Q81284330-E7D70638-D8BA-4B10-A6F0-FB11C994470D @default.
- Q81284330 P2093 Q81284330-F346E3CE-8664-43CA-AB92-768B4AA7D48F @default.
- Q81284330 P2093 Q81284330-FDB3838F-03AC-4DBB-A209-DD723CD37D58 @default.
- Q81284330 P304 Q81284330-129406AC-2C07-4632-AFD3-BF1C5C38531C @default.
- Q81284330 P31 Q81284330-868FDF3E-FC0E-4430-810C-50935D323F9C @default.
- Q81284330 P356 Q81284330-E5FE69FE-7B53-4104-86CE-206A2B475162 @default.
- Q81284330 P433 Q81284330-2EF56325-ABF7-45CE-8B07-8AB319ABAF7D @default.
- Q81284330 P478 Q81284330-85ED7C1D-4D2F-46B6-B8DE-086CFA2CFD23 @default.
- Q81284330 P577 Q81284330-FDF2EABE-4C45-4048-B307-08A7A441655E @default.
- Q81284330 P698 Q81284330-898D8DDB-D500-43C2-8267-1F274EC24DD5 @default.
- Q81284330 P921 Q81284330-190146EF-40BC-4E7E-AFC2-8F0FFCA16C8A @default.
- Q81284330 P356 ARCHDERM.141.1.31 @default.
- Q81284330 P698 15655139 @default.
- Q81284330 P1433 Q15749524 @default.
- Q81284330 P1476 "Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis" @default.
- Q81284330 P2093 "Alan Menter" @default.
- Q81284330 P2093 "Ivor Caro" @default.
- Q81284330 P2093 "Kenneth Gordon" @default.
- Q81284330 P2093 "Nicole Li" @default.
- Q81284330 P2093 "Scott Glazer" @default.
- Q81284330 P2093 "Tiffani Hamilton" @default.
- Q81284330 P2093 "Wayne Carey" @default.
- Q81284330 P2093 "Wayne Gulliver" @default.
- Q81284330 P304 "31-38" @default.
- Q81284330 P31 Q13442814 @default.